Fibrinogen | Coagulation - MedSchool
Sign up to start your free trial of MedSchool Premium!Get Started
 
Coagulation
 
 
 

Fibrinogen

 
 
Bookmark

Overview

      • Normal Range

      • 1.5 - 4.5 g/L
    • Important Lab Points

    • Fibrinogen is not routinely measured as part of a coagulation screen.
    • The ‘derived’ fibrinogen level is often reported with the coag result and is estimated based on the prothromin time curve. It is not an accurate estimate of fibrinogen concentrations and should not be used.
    • A dedicated fibrinogen assay should be ordered to determine the fibrinogen concentration.

Hyperfibrinogenaemia

  • Elevated serum fibrinogen.
    • Causes of Hyperfibrinogenaemia

    • Physiological in elderly patients
    • Acute phase reactant - infection, inflammation, malignancy
    • Pregnancy

Hypofibrinogenaemia

  • Reduced serum fibrinogen.
    • Causes of Hypofibrinogenaemia

    • Congenital deficiency - hypofibrinogenaemia, afibrinogenaemia, dysfibrinogenaemia
    • Reduced synthesis - liver impairment
    • Consumption - DIC, cancers, thrombolytic therapy, snake bite
    • Haemodilution - massive transfusion
Last updated on January 19th, 2018
 
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
 
 

Read More...

 Barras M. Anti-Xa assays. Australian Prescriber. 2013 Jun 1;36(3). Besser MW, MacDonald SG. Acquired hypofibrinogenemia: current perspectives. Journal of blood medicine. 2016;7:217. Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the'derived'fibrinogen measurement. Blood coagulation & fibrinolysis. 1994 Dec 1;5(6):955-7.
Chng WJ, Sum C, Kuperan P. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital. Singapore medical journal. 2005 Sep;46(9):450.
 Chopra N, Doddamreddy P, Grewal H, Kumar PC. An elevated D-dimer value: a burden on our patients and hospitals. International journal of general medicine. 2012;5:87. Eisenberg JM, Clarke JR, Sussman SA. Prothrombin and Partial Thromboplastin Times as Preoperative Screening Tests. Arch Surg. 1982; 117(1): 48-51. Eisenberg JM, Clarke JR, Sussman SA. Prothrombin and Partial Thromboplastin Times as Preoperative Screening Tests. Arch Surg. 1982; 117(1): 48-51.  Giannitsis E, Mair J, Christersson C, Siegbahn A, Huber K, Jaffe AS, Peacock WF, Plebani M, Thygesen K, Möckel M, Mueller C. How to use D-dimer in acute cardiovascular care. European Heart Journal: Acute Cardiovascular Care. 2017 Feb;6(1):69-80. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. InMayo Clinic Proceedings 2007 Jul 31 (Vol. 82, No. 7, pp. 864-873). Elsevier. Katayev A, Balciza C, Seccombe DW. Establishing Reference Intervals for Clinical Laboratory Test Results: Is There a Better Way?. Am J Clin Pathol. 2010; 133(2): 179. Levi M, Opal SM. Coagulation abnormalities in critically ill patients. Critical care. 2006 Jul 19;10(4):222. Lowe GD, Rumley A, Mackie IJ. Plasma fibrinogen. Ann Clin Biochem. 2004; 41: 430. Mani H. Interpretation of coagulation test results under direct oral anticoagulants. International journal of laboratory hematology. 2014 Jun 1;36(3):261-8. Oliver Speer O, Schmugge M, Metzger C, Albisetti M. Reference Ranges of Coagulation Tests. Methods in molecular biology. 2013; 992: 85. Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian journal of anaesthesia. 2014 Sep;58(5):515. Peyvandi F, Garagiola I, Baronciani L. Role of von Willebrand factor in the haemostasis. Blood Transfusion. 2011 May;9(Suppl 2):s3. Wakai A, Gleeson A, Winter D. Role of fibrin D-dimer testing in emergency medicine. Emergency Medicine Journal. 2003 Jul 1;20(4):319-25.
Feedback